iTeos Therapeutics, Inc.
ITOSDelisted Aug 29, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001808865
iTeos Therapeutics, Inc. was delisted on Aug 29, 2025; its insiders filed their last Form 4 on Aug 29, 2025; 137 institutions reported holding it in 13F filings for Q2 2025, worth $377.0M in total; no superinvestor held it.
13F holders, Q2 2023
Institutional positions in iTeos Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 146
- −7 vs. Q1 2023
- Shares held
- 34.8M
- −1.22M (−3.4%) vs. Q1 2023
- Total value
- $460.4M
- −$28.4M (−5.8%) vs. Q1 2023
- New holders
- 18
- 57 more added
- Sold out
- 25
- 47 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ITOS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 1 | $2.35K |
| Q2 2025 | 137 | $377.0M |
| Q1 2025 | 132 | $220.7M |
| Q4 2024 | 137 | $262.2M |
| Q3 2024 | 151 | $373.3M |
| Q2 2024 | 139 | $536.8M |
| Q1 2024 | 136 | $471.2M |
| Q4 2023 | 138 | $383.4M |
| Q3 2023 | 144 | $388.6M |
| Q2 2023 | 146 | $460.4M |
| Q1 2023 | 153 | $488.9M |
| Q4 2022 | 146 | $707.3M |
| Q3 2022 | 143 | $698.2M |
| Q2 2022 | 153 | $768.1M |
| Q1 2022 | 159 | $1.17B |
| Q4 2021 | 118 | $1.55B |
| Q3 2021 | 77 | $841.3M |
| Q2 2021 | 83 | $755.8M |
| Q1 2021 | 81 | $1.03B |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding iTeos Therapeutics, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Rafferty Asset Management, LLC | 86,598 | $1.15M | 0.01% | −27,452−24.1% | Reduced |
| Readystate Asset Management LP | 88,391 | $1.17M | 0.12% | +88,391 | New |
| DAFNA Capital Management LLC | 98,560 | $1.30M | 0.36% | 00.0% | Unchanged |
| Victory Capital Management Inc | 98,782 | $1.31M | 0.00% | +14,333+17.0% | Added |
| Empowered Funds, LLC | 101,304 | $1.34M | 0.05% | +101,304 | New |
| EA Series Trust | 101,304 | $1.34M | 0.05% | +101,304 | New |
| Los Angeles Capital Management LLC | 110,022 | $1.46M | 0.01% | +2,800+2.6% | Added |
| Bank of America Corp | 115,864 | $1.53M | 0.00% | −41,766−26.5% | Reduced |
| Verition Fund Management LLC | 116,283 | $1.54M | 0.02% | +116,283 | New |
| Panagora Asset Management Inc | 121,039 | $1.60M | 0.01% | +4,305+3.7% | Added |
| Ameriprise Financial Inc | 133,434 | $1.77M | 0.00% | −5,206−3.8% | Reduced |
| FMR LLC | 140,717 | $1.86M | 0.00% | −71,998−33.8% | Reduced |
| Sectoral Asset Management Inc | 146,576 | $1.94M | 0.32% | +58,203+65.9% | Added |
| Vontobel Holding Ltd. | 146,576 | $1.94M | 0.02% | +58,203+65.9% | Added |
| Principal Financial Group Inc | 146,787 | $1.94M | 0.00% | −8,370−5.4% | Reduced |
| Baker Bros. Advisors LP | 150,346 | $1.99M | 0.01% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 167,804 | $2.22M | 0.05% | −99,141−37.1% | Reduced |
| Morgan Stanley | 176,680 | $2.34M | 0.00% | −386,534−68.6% | Reduced |
| Charles Schwab Investment Management Inc | 190,913 | $2.53M | 0.00% | +7,947+4.3% | Added |
| Invesco Ltd. | 215,367 | $2.85M | 0.00% | −373,194−63.4% | Reduced |
| Bank of Montreal | 171,389 | $3.10M | 0.00% | +171,389 | New |
| Citigroup Inc | 234,667 | $3.11M | 0.00% | −54,218−18.8% | Reduced |
| Bank of New York Mellon Corp | 261,869 | $3.47M | 0.00% | −860.0% | Reduced |
| Northern Trust Corp | 266,838 | $3.53M | 0.00% | +14,819+5.9% | Added |
| Prudential Financial Inc | 291,051 | $3.85M | 0.01% | +133,690+85.0% | Added |
| Barclays PLC | 314,880 | $4.17M | 0.00% | +57,924+22.5% | Added |
| Artal Group S.A. | 400,000 | $5.30M | 0.17% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 413,200 | $5.47M | 0.01% | +83,300+25.3% | Added |
| Jacobs Levy Equity Management, Inc | 490,380 | $6.49M | 0.04% | −24,545−4.8% | Reduced |
| Geode Capital Management, LLC | 502,012 | $6.65M | 0.00% | +20,773+4.3% | Added |
| Dimensional Fund Advisors LP | 578,649 | $7.66M | 0.00% | +163,043+39.2% | Added |
| 683 Capital Management, LLC | 585,000 | $7.75M | 0.75% | +105,000+21.9% | Added |
| Octagon Capital Advisors LP | 596,000 | $7.89M | 1.10% | 00.0% | Unchanged |
| Candriam Luxembourg S.C.A. | 611,547 | $8.10M | 0.06% | −127,970−17.3% | Reduced |
| Saturn V Capital Management LLC | 636,158 | $8.42M | 4.67% | +155,505+32.4% | Added |
| Goldman Sachs Group Inc | 643,665 | $8.52M | 0.00% | +205,556+46.9% | Added |
| Millennium Management LLC | 826,102 | $10.9M | 0.01% | +297,830+56.4% | Added |
| Citadel Advisors LLC | 1,195,269 | $15.8M | 0.02% | −248,231−17.2% | Reduced |
| State Street Corp | 1,565,202 | $20.7M | 0.00% | −262,189−14.3% | Reduced |
| MPM Oncology Impact Management LP | 1,745,943 | $23.1M | 4.65% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,773,352 | $23.5M | 0.00% | +3630.0% | Added |
| BVF Inc | 1,810,835 | $24.0M | 0.67% | 00.0% | Unchanged |
| Boxer Capital, LLC | 2,154,058 | $28.5M | 1.32% | 00.0% | Unchanged |
| MPM Asset Management LLC | 2,738,785 | $36.3M | 17.78% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 4,417,259 | $58.5M | 1.10% | 00.0% | Unchanged |
| BlackRock Inc. | 4,680,194 | $62.0M | 0.00% | +216,888+4.9% | Added |
| AXA S.A. | 0 | $0 | 0.00% | −218,600−100.0% | Sold out |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −216,700−100.0% | Sold out |
| Integral Health Asset Management, LLC | 0 | $0 | 0.00% | −180,000−100.0% | Sold out |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −148,594−100.0% | Sold out |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −72,246−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −54,115−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −46,448−100.0% | Sold out |
| Vident Investment Advisory, LLC | 0 | $0 | 0.00% | −32,887−100.0% | Sold out |
| Prairiewood Capital, LLC | 0 | $0 | 0.00% | −32,269−100.0% | Sold out |
| Caxton Associates LP | 0 | $0 | 0.00% | −30,695−100.0% | Sold out |
| Ziegler Capital Management, LLC | 0 | $0 | 0.00% | −21,704−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −13,573−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −13,251−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −11,952−100.0% | Sold out |
| DekaBank Deutsche Girozentrale | 0 | $0 | 0.00% | −11,300−100.0% | Sold out |
| Maryland State Retirement & Pension System | 0 | $0 | 0.00% | −10,038−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −6,177−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −6,056−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −3,620−100.0% | Sold out |
| James Investment Research Inc | 0 | $0 | 0.00% | −2,680−100.0% | Sold out |
| EcoR1 Capital, LLC | 0 | $0 | 0.00% | −1,300−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −900−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −226−100.0% | Sold out |
| Fisher Asset Management, LLC | 0 | $0 | 0.00% | −102−100.0% | Sold out |
| Fifth Third Bancorp | 0 | $0 | 0.00% | −25−100.0% | Sold out |